Clinical CNS Drugs
publishes original research, expert reviews and thematic issues in all core areas of translational and clinical CNS & peripheral nervous system drug research.
The journal publishes pre-clinical and clinical studies on the development of new CNS and peripheral nervous system agents. Clinical studies of new reported drugs include Phase 1 - IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and to pharmacologists.